Keyword: rheumatoid arthritis
Plant Construction & Process Technology
27.04.2017
- Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...
News
24.03.2016
- US drugmaker Bristol-Myers Squibb (BMS) has signed an agreement to acquire Padlock Therapeutics, a privately owned biotechnology firm based at Cambridge, Massachusetts, which...
News
02.02.2016
- Rheumatoid arthritis sufferers in England will soon be able to benefit from a cheaper generic version of US pharmaceutical producer Merck’s and the world’s best-selling medicines...
Plant Construction & Process Technology
07.10.2015
- With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...
News
21.05.2015
- Johnson & Johnson's Janssen Pharmaceuticals offshoot has told analysts it plans to seek regulatory approval for more than 10 new drugs up to 2019, each with the potential to...
News
24.02.2015
- French drugmaker Sanofi and Dutch biotech Lead Pharma have entered a research collaboration and license agreement to discover, develop and commercialize small-molecule therapies...
News
07.02.2014
- Pharmaceuticals - Many biologic drug developers can be pleased with how well their products have performed in the market place. Blockbuster products such as Abbvie's (ex-Abbott)...
News
01.07.2013
- European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid...
